Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis is a research paper published in Metabolites (2024). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Multiple Sclerosis Society (U.S.)
Grant: RG4311A4/4
National Multiple Sclerosis Society (U.S.)
Grant: RG-1807-31964
National Multiple Sclerosis Society (U.S.)
Grant: RG-2111–38733
National Multiple Sclerosis Society (U.S.)
Grant: NS112727
National Multiple Sclerosis Society (U.S.)
Grant: AI144004
National Multiple Sclerosis Society (U.S.)
Grant: A10270
National Multiple Sclerosis Society (U.S.)
Grant: A30967
National Institutes of Health
Grant: 5R01NS112727-05
Endogenous metabolite restricts GM-CSF signaling pathway in pathogenic macrophages to ameliorate CNS Autoimmunity
National Institutes of Health
Grant: 5R01AI144004-03
Novel Regulation and Targeting of Macrophages Metabolism in Neuroinflammatory Disorders
NIAID NIH HHS
Grant: R01 AI144004
NINDS NIH HHS
Grant: R01 NS112727
Fields of Study
Keywords
Sustainable Development Goals